|

Cardioprotection on Chemotherapy-Induced Cardiotoxicity

RECRUITINGPhase 3Sponsored by Ain Shams University
Actively Recruiting
PhasePhase 3
SponsorAin Shams University
Started2023-07-18
Est. completion2025-03-30
Eligibility
Age1 Year – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06853951

Summary

The aim of the present study is to evaluate the protective impact of cardioprotective medications on the chemotherapy- induced cardiotoxicity.

Eligibility

Age: 1 Year – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Willingness of the legal representative of research participant to participate in the study by giving "informed consent."
* Ability to take oral medication.
* Age 2-18 years at the time of diagnosis.

Exclusion Criteria:

* Documented allergy to cardioprotective medications

Conditions2

CardiotoxicityHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.